← Open Payments lookup

CHEVELLE PARKER: Open Payments

NPI 1922348465 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,160 in 16 payments from 8 companies in 2025. Trend: 2023 $762 · 2024 $692 · 2025 $1,160

Food & beverage: $1,160
CompanyPaymentsAmount
Insulet Corporation2$263
Corcept Therapeutics3$253
BETA BIONICS, INC.5$238
Bayer Healthcare Pharmaceuticals Inc.1$120
Lilly USA, LLC1$115
Dexcom, Inc.1$104
Medtronic, Inc.2$50
AstraZeneca Pharmaceuticals LP1$17

Products named: Omnipod, Korlym, iLet Bionic Pancreas, Kerendia, ZEPBOUND, Dexcom G6 Transmitter, MINIMED 780G, FARXIGA.

Industry payments across LA — which companies pay providers there.